[go: up one dir, main page]

HRP20020672B1 - Pluraflavins and derivatives thereof, process for their preparation and use thereof - Google Patents

Pluraflavins and derivatives thereof, process for their preparation and use thereof

Info

Publication number
HRP20020672B1
HRP20020672B1 HR20020672A HRP20020672A HRP20020672B1 HR P20020672 B1 HRP20020672 B1 HR P20020672B1 HR 20020672 A HR20020672 A HR 20020672A HR P20020672 A HRP20020672 A HR P20020672A HR P20020672 B1 HRP20020672 B1 HR P20020672B1
Authority
HR
Croatia
Prior art keywords
groups
group
alkenyl
independently selected
alkyl groups
Prior art date
Application number
HR20020672A
Other languages
English (en)
Croatian (hr)
Inventor
Vertesy Laszlo
Ehrlich Klaus
Knauf Martin
Wink Joachim
P. Barbone Francis
A. Powers Elaine
A. Cashman Elizabeth
Original Assignee
Sanofi-Aventis Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis Deutschland Gmbh filed Critical Sanofi-Aventis Deutschland Gmbh
Publication of HRP20020672A2 publication Critical patent/HRP20020672A2/hr
Publication of HRP20020672B1 publication Critical patent/HRP20020672B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/58Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound through only acyclic carbon atoms to a non-saccharide heterocyclic ring, e.g. bleomycin, phleomycin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HR20020672A 2000-02-18 2002-08-14 Pluraflavins and derivatives thereof, process for their preparation and use thereof HRP20020672B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00103540A EP1125944A1 (de) 2000-02-18 2000-02-18 Pluraflavine und Derivate davon, Verfahren zu ihrer Herstellung und Verwendung derselben
PCT/EP2001/001660 WO2001060832A2 (en) 2000-02-18 2001-02-15 Pluraflavins and derivatives thereof, process for their preparation and use thereof

Publications (2)

Publication Number Publication Date
HRP20020672A2 HRP20020672A2 (en) 2004-12-31
HRP20020672B1 true HRP20020672B1 (en) 2010-12-31

Family

ID=8167898

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20020672A HRP20020672B1 (en) 2000-02-18 2002-08-14 Pluraflavins and derivatives thereof, process for their preparation and use thereof

Country Status (31)

Country Link
US (1) US6500936B2 (hu)
EP (2) EP1125944A1 (hu)
JP (1) JP4801307B2 (hu)
KR (1) KR100743380B1 (hu)
CN (1) CN1162441C (hu)
AR (1) AR027436A1 (hu)
AT (1) ATE255120T1 (hu)
AU (2) AU4240401A (hu)
BR (1) BR0108128A (hu)
CA (1) CA2400237C (hu)
CZ (1) CZ303810B6 (hu)
DE (1) DE60101313T2 (hu)
DK (1) DK1259523T3 (hu)
EE (1) EE05137B1 (hu)
ES (1) ES2207609T3 (hu)
HK (1) HK1052709B (hu)
HR (1) HRP20020672B1 (hu)
HU (1) HU228332B1 (hu)
IL (2) IL151216A0 (hu)
ME (1) ME00179B (hu)
MX (1) MXPA02006919A (hu)
NO (1) NO323413B1 (hu)
PL (1) PL204842B1 (hu)
PT (1) PT1259523E (hu)
RS (1) RS49991B (hu)
RU (1) RU2255940C2 (hu)
SI (1) SI1259523T1 (hu)
SK (1) SK286691B6 (hu)
TR (1) TR200302180T4 (hu)
WO (1) WO2001060832A2 (hu)
ZA (1) ZA200206795B (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6989386B2 (en) * 2002-04-30 2006-01-24 Dana-Farber Cancer Institute Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making same
CN101921300B (zh) * 2009-06-10 2014-04-02 上海来益生物药物研究开发中心有限责任公司 一种异黄酮苷类化合物及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990009435A1 (en) * 1989-02-07 1990-08-23 Abbott Laboratories Altromycin compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0274545B1 (en) * 1986-07-21 1992-12-02 Kyowa Hakko Kogyo Co., Ltd. Novel substances dc-92b and dc-92d, and process for their preparation
WO1990000935A1 (en) * 1988-07-22 1990-02-08 Masco Corporation Of Indiana A small hand-held shower head for domestic sinks connected to a faucet
US5001058A (en) * 1988-09-19 1991-03-19 Bristol-Myers Company BU-3839T antibiotic
US5168100A (en) * 1990-03-16 1992-12-01 Sapporo Breweries Limited Hp530 compounds and process for preparing the same
CA2778804C (en) * 2007-07-06 2015-12-22 Rite-Hite Holding Corporation Retractable safety barriers and methods of operating same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990009435A1 (en) * 1989-02-07 1990-08-23 Abbott Laboratories Altromycin compounds

Also Published As

Publication number Publication date
US20020028921A1 (en) 2002-03-07
WO2001060832A2 (en) 2001-08-23
HUP0204393A3 (en) 2007-10-29
HUP0204393A2 (hu) 2003-07-28
BR0108128A (pt) 2003-02-25
DE60101313T2 (de) 2004-09-30
US6500936B2 (en) 2002-12-31
DK1259523T3 (da) 2004-03-22
NO20023845D0 (no) 2002-08-14
AU2001242404B2 (en) 2005-04-14
SK286691B6 (sk) 2009-03-05
NO20023845L (no) 2002-10-10
MXPA02006919A (es) 2004-04-05
EP1125944A1 (de) 2001-08-22
PL204842B1 (pl) 2010-02-26
HU228332B1 (en) 2013-03-28
AR027436A1 (es) 2003-03-26
SI1259523T1 (en) 2004-04-30
ME00179B (me) 2011-02-10
YU57602A (sh) 2005-11-28
WO2001060832A3 (en) 2002-01-31
EE200200438A (et) 2003-12-15
JP4801307B2 (ja) 2011-10-26
CZ303810B6 (cs) 2013-05-15
RU2002124772A (ru) 2004-02-20
PT1259523E (pt) 2004-04-30
HK1052709B (zh) 2005-02-04
CN1162441C (zh) 2004-08-18
AU4240401A (en) 2001-08-27
ZA200206795B (en) 2003-11-19
JP2003523346A (ja) 2003-08-05
IL151216A (en) 2009-12-24
DE60101313D1 (de) 2004-01-08
KR100743380B1 (ko) 2007-07-30
EE05137B1 (et) 2009-02-16
HRP20020672A2 (en) 2004-12-31
NO323413B1 (no) 2007-04-30
PL358297A1 (en) 2004-08-09
SK11802002A3 (sk) 2003-02-04
EP1259523B1 (en) 2003-11-26
HK1052709A1 (en) 2003-11-21
CZ20022826A3 (cs) 2002-11-13
ATE255120T1 (de) 2003-12-15
RU2255940C2 (ru) 2005-07-10
EP1259523A2 (en) 2002-11-27
ES2207609T3 (es) 2004-06-01
MEP28608A (en) 2010-10-10
KR20020086539A (ko) 2002-11-18
CA2400237A1 (en) 2001-08-23
CN1404484A (zh) 2003-03-19
TR200302180T4 (tr) 2004-03-22
IL151216A0 (en) 2003-04-10
CA2400237C (en) 2008-12-30
RS49991B (sr) 2008-09-29

Similar Documents

Publication Publication Date Title
FI970317A (fi) Antiproliferatiivisina aineina ja Garft-inhibiittoreina käyttökelpoisia yhdisteitä
BR0317094A (pt) Sal de alumìnio livre de zircÈnio, e, composição antiperspirante
ES2107698T3 (es) Benzoilguanidinas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento, como inhibidores del intercambio celular de na+/h+ o como agente de diagnostico, asi como medicamento que las contiene.
ES542322A0 (es) Un procedimiento para la preparacion de derivados de la 2 pirimidinil-1-piperazina
AR012489A1 (es) Tiofenopiridinas antagonistas del factor de liberacion de corticotropina. procedimiento para su preparacion, el uso de las mismas en la preparacionde un medicamento, composicion farmaceutica que las comprende, procedimiento para la preparacion de dicha composicion, un compuesto intermediario y
AR028624A1 (es) Heterociclilalquilaminas como antagonistas de receptores muscarinicos
ATE175661T1 (de) Benzamid-derivate als vasopressin-antagonisten
RS49588B (sr) Derivati benzopirana koji poseduju leukotrien-antagonističko dejstvo
MY133445A (en) 2-arylethyl-(piperidin-4-ylmethyl)amine derivetives
AR064188A1 (es) Derivados de indolizina, procesos de obtencion y composiciones farmaceuticas que los contienen.
MA26767A1 (fr) Hydroxamates de sulfonamide
ATE245157T1 (de) 3,9-diazabicyclo-(3.3.1)-nonanylderivate, verfahren und intermediate für ihre darstellung und sie enthaltende pharmazeutische zusammensetzungen
ES2115220T3 (es) Nuevo uso de compuestos bis-heterociclicos como agentes antiinflamatorios y composiciones farmaceuticas de los mismos.
ES496038A0 (es) Procedimiento para la obtencion de 2-hidroxialquil-3,4,5- trihidroxi-piperidinas
ES503837A0 (es) Procedimiento para la preparacion de 3,1-benzoxazin-2-onas
SE8406302L (sv) Nya aminoguanidinderivat och ett forfarande for deras framstellning
BR0012478A (pt) Derivados de aminotiazóis, sua preparação e composição farmacêuticas contendo os mesmos
CO4770917A1 (es) Compuestos de dihalopropeno, su uso e intermedios para su produccion
YU44301A (sh) 5ht1 antagonisti za antidepresantnu terapiju
HRP20020672B1 (en) Pluraflavins and derivatives thereof, process for their preparation and use thereof
ES2146643T3 (es) Fenilcarboxamida-isoxazoles y sus sales, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que lo contienen.
NO994937L (no) Krympingsreduserende middel for sementsammensetninger
PE8497A1 (es) Dihidrobenzofurano y compuestos relacionados utiles como agentes antiinflamatorios
FI845095L (fi) Aminoimidazolonderivat saosom histamin-h2-antagonister.
HRP20030125B1 (en) Prodrugs to nmda receptor ligands

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH, DE

B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20170111

Year of fee payment: 17

PBON Lapse due to non-payment of renewal fee

Effective date: 20180215